Company:  REVANCE THERAPEUTICS, INC ... (RVNC)
Form Type:  8-K
Filing Date:  10/11/2018 
CIK:  0001479290 
Address:  7555 GATEWAY BLVD. 
City, State, Zip:  NEWARK, California 94560 
Telephone:  510-742-3400 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$24.62  
Change: 
-0.15 (-0.61%)  
Trade Time: 
10:24 AM EST  
Market Cap: 
$909.41M
Trade RVNC now with 

© 2018  
Description of Business
Revance Therapeutics, Inc. is a clinical-stage biotechnology company focused on the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic indications. We are leveraging our proprietary portfolio of botulinum toxin type A compounds, formulated with our patented and proprietary peptide technology, to address unmet needs in large and growing neuromodulator markets. Our proprietary peptide technology enables delivery of botulinum toxin type A through two investigational drug product candidates, DaxibotulinumtoxinA for Injection (RT002), or RT002 injectable, and DaxibotulinumtoxinA Topical. We are pursuing clinical development for RT002 injectable in a broad spectrum of aesthetic and therapeutic indications and are planning to conduct additional preclinical development of our topical program. Neither of our product candidates contains albumin or any other animal or human-derived materials.
Register and access this filing in:     
  FORM 8-K
    SECTION 5 CORPORATE GOVERNANCE
      ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ...
    SIGNATURES